콘텐츠로 건너뛰기
Merck
  • Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.

Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy (2008-03-05)
Pontus Juréen, Jim Werngren, Juan-Carlos Toro, Sven Hoffner
초록

Thirty-four pyrazinamide-resistant and 37 pyrazinamide-susceptible Mycobacterium tuberculosis complex strains were analyzed for pncA gene mutations. None of the sensitive strains had any mutations, apart from silent mutations, whereas all but one resistant strain showed pncA mutations. By using sequencing as a means of early resistance detection, the inconsistency of phenotypic pyrazinamide assays can be circumvented.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Pyrazinecarboxamide